200 related articles for article (PubMed ID: 37562163)
1. Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development.
de Queiroz Cavalcanti SA; de Almeida LA; Gasparotto J
J Neuroimmunol; 2023 Sep; 382():578171. PubMed ID: 37562163
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
3. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
4. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
5. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
6. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
7. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
8. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
Front Immunol; 2022; 13():937555. PubMed ID: 35812394
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis.
Manfready RA; Goetz CG; Keshavarzian A
Int Rev Neurobiol; 2022; 167():81-99. PubMed ID: 36427960
[TBL] [Abstract][Full Text] [Related]
12. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
14. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
15. Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease.
Schmit KJ; Garcia P; Sciortino A; Aho VTE; Pardo Rodriguez B; Thomas MH; Gérardy JJ; Bastero Acha I; Halder R; Cialini C; Heurtaux T; Ostahi I; Busi SB; Grandmougin L; Lowndes T; Singh Y; Martens EC; Mittelbronn M; Buttini M; Wilmes P
Cell Rep; 2023 Sep; 42(9):113071. PubMed ID: 37676767
[TBL] [Abstract][Full Text] [Related]
16. A nutritional approach to microbiota in Parkinson's disease.
Uyar GÖ; Yildiran H
Biosci Microbiota Food Health; 2019; 38(4):115-127. PubMed ID: 31763115
[TBL] [Abstract][Full Text] [Related]
17. Oral and intestinal dysbiosis in Parkinson's disease.
Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment.
Salim S; Ahmad F; Banu A; Mohammad F
J Adv Res; 2023 Aug; 50():83-105. PubMed ID: 36332796
[TBL] [Abstract][Full Text] [Related]
19. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
Perez-Pardo P; Dodiya HB; Engen PA; Forsyth CB; Huschens AM; Shaikh M; Voigt RM; Naqib A; Green SJ; Kordower JH; Shannon KM; Garssen J; Kraneveld AD; Keshavarzian A
Gut; 2019 May; 68(5):829-843. PubMed ID: 30554160
[TBL] [Abstract][Full Text] [Related]
20. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease.
Huang Y; Liao J; Liu X; Zhong Y; Cai X; Long L
Front Cell Infect Microbiol; 2021; 11():615075. PubMed ID: 33968794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
